Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04723602Phase 1Completed
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Ebola Virus DiseaseMarburg Virus Disease
PrincipalinvestigatorStart date: 2021-01-06

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Oklahoma Blood Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alison Heald, MD

Sarepta Therapeutics, Inc.

Moderately Similar
4 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaMarburg Virus Disease
Similarity Score30%

David Hoover, MD

ICON plc

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaMarburg Virus Disease

Worked with same sponsors:

Albert B. Sabin Vaccine InstituteICON plc+1 more
Collaborated on 1 trial
Similarity Score24%

Michael Stevenson, MD

Oklahoma Blood Institute

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaMarburg Virus Disease

Worked with same sponsors:

Albert B. Sabin Vaccine InstituteICON plc+1 more
Collaborated on 1 trial
Similarity Score24%

Roxana Rustomjee, MBChB

The Albert B. Sabin Vaccine Institute

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaMarburg Virus Disease

Worked with same sponsors:

Albert B. Sabin Vaccine InstituteICON plc+1 more
Collaborated on 1 trial
Similarity Score24%

Jo Collier, MBChB

Quotient Clinical

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Mark Kieh

Redemption Hospital

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Bailah Leigh, MD

University of Sierra Leone

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Michael C Sneller, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
12 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Angela Huttner, MD

University of Geneva, Switzerland

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Myron M Levine, MD, DTPH

University of Maryland, Baltimore

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04723602Phase 1PrincipalInvestigator

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Ebola Virus DiseaseMarburg Virus Disease
Completed

All 1 trials loaded